ANTICIPATE
Prevention of ANThracycline‐Induced Cardiac dysfunction by dexrazoxane In PATients with diffusE large B‐cell lymphoma: a prospective randomized trial
- Stage
- inclusie
- Medicine
- Population
- ASCVD
- Phase
- III
- First Patient In
- 1 June 2024
- Last Patient In
- 1 November 2027
- Last Patient Last Visit
- 1 February 2028
Inclusion period, 702 days remaining
Study Director
dr. F.J.F. Broeyer
Cardioloog
Office Contact
